QQ客服 官方微博 反馈留言

	Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors.
	Ndikuryayo, Ferdinand; Kang, Wei-Ming; Wu, Feng-Xu; Yang, Wen-Chao*; Yang, Guang-Fu*
刊名	European journal of medicinal chemistry
	2019
卷号	166页码:22-31
关键词	4-Hydroxyphenylpyruvate dioxygenase Alkaptonuria Hawkinisinuria Hydrophobicity-oriented drug design (HODD) Inhibitors Type I tyrosinemia
ISSN号	0223-5234
DOI	10.1016/j.ejmech.2019.01.032
URL标识	查看原文
WOS记录号	WOS:000461402400003
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5156774
专题	华中师范大学
作者单位	1.[Ndikuryayo, Ferdinand 2.Yang, Guang-Fu 3.Yang, Wen-Chao 4.Kang, Wei-Ming 5.Wu, Feng-Xu 6.Yang, WC 7.Yang, GF] Cent China Normal Univ, Int Joint Res Ctr Intelligent Biosensor Technol &, Key Lab Pesticide & Chem Biol, Minist Educ,Chem Biol Ctr,Coll Chem, Wuhan 430079, Hubei, Peoples R China.
推荐引用方式 GB/T 7714	Ndikuryayo, Ferdinand,Kang, Wei-Ming,Wu, Feng-Xu,et al. Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors.[J]. European journal of medicinal chemistry,2019,166:22-31.
APA	Ndikuryayo, Ferdinand,Kang, Wei-Ming,Wu, Feng-Xu,Yang, Wen-Chao*,&Yang, Guang-Fu*.(2019).Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors..European journal of medicinal chemistry,166,22-31.
MLA	Ndikuryayo, Ferdinand,et al."Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors.".European journal of medicinal chemistry 166(2019):22-31.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。